Received May 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TL74Y | — |
Accidental exposure while preparing drug for administration; Accidental exposure while preparing drug for administration; Product complaint; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of occupational exposure via skin contact with product in a female patient who received Herpes zoster (Shingrix) (batch number TL74Y, expiry date 19-MAY-2028) for prophylaxis. This case was associated with a product complaint. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced occupational exposure via skin contact with product (Verbatim: Accidental exposure while preparing drug for administration), inadvertent exposure to vaccine (Verbatim: Accidental exposure while preparing drug for administration) and pharmaceutical product complaint (Verbatim: Product complaint). The outcome of the occupational exposure via skin contact with product, inadvertent exposure to vaccine and pharmaceutical product complaint were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-MAY-2026 A pharmacy technician reported a possible product quality complaint after receiving the first shipment of the new formulation. She stated that one of the syringes had been left on the counter when the plunger backed out on its own and the liquid spilled onto the counter. She also reported a potential issue with one of the injectors used for a patient. The case was placed in the healthcare professional (HCP) queue for a Shingrix-trained agent to call back. An outbound call was made on 21-MAY-2025. The original caller was unavailable; however, two other reporters who had experienced the events were available. The pharmacist who reported the plunger issue stated that the cap had not been removed and that the syringe had been out of refrigeration for less than 10 minutes. She reported holding the syringe by the barrel while documenting the lot number when she suddenly noticed liquid on her hand, indicating accidental exposure. She added that the plunger had since been reinserted and suggested that internal pressure may have caused it to dislodge spontaneously.